Changing Chinese Market Dynamics Hit Merck Where It Hurts

China gets more complicated as multinational drug makers venture deep into it. Even with a local savvy business partner, Merck is learning to navigate through fast-shifting market dynamics amid policy changes, consumer perceptions of foreign brands, and competition from local firms as it takes stock of its market access, pricing and life cycle management strategies.

Merck's Gardasil Sales Are Battered In China

More from Market Access

More from In Vivo